Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Men, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa.

Chikovore J, Gillespie N, McGrath N, Orne-Gliemann J, Zuma T; ANRS 12249 TasP Study Group.

AIDS Care. 2016;28 Suppl 3:74-82. doi: 10.1080/09540121.2016.1178953.

PMID:
27421054
2.

Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.

Boyer S, Iwuji C, Gosset A, Protopopescu C, Okesola N, Plazy M, Spire B, Orne-Gliemann J, McGrath N, Pillay D, Dabis F, Larmarange J; ANRS 12249 TasP study group.

AIDS Care. 2016;28 Suppl 3:39-51. doi: 10.1080/09540121.2016.1164808.

PMID:
27421051
3.

"It is better to die": experiences of traditional health practitioners within the HIV treatment as prevention trial communities in rural South Africa (ANRS 12249 TasP trial).

Moshabela M, Zuma T, Orne-Gliemann J, Iwuji C, Larmarange J, McGrath N; ANRS 12249 TasP Study Group.

AIDS Care. 2016;28 Suppl 3:24-32. doi: 10.1080/09540121.2016.1181296.

PMID:
27421049
4.

Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa.

Orne-Gliemann J, Zuma T, Chikovore J, Gillespie N, Grant M, Iwuji C, Larmarange J, McGrath N, Lert F, Imrie J; TasP Study Group.

AIDS Care. 2016;28 Suppl 3:14-23. doi: 10.1080/09540121.2016.1164805.

PMID:
27421048
5.

Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster-randomized trial in rural South Africa.

Plazy M, Farouki KE, Iwuji C, Okesola N, Orne-Gliemann J, Larmarange J, Lert F, Newell ML, Dabis F, Dray-Spira R; Anrs 12249 Tasp Study Group.

J Int AIDS Soc. 2016 Jun 1;19(1):20913. doi: 10.7448/IAS.19.1.20913. eCollection 2016.

6.

Strengthening universal HIV 'test-and-treat' approaches with social science research.

Camlin CS, Seeley J, Viljoen L, Vernooij E, Simwinga M, Reynolds L, Reis R, Plank R, Orne-Gliemann J, McGrath N, Larmarange J, Hoddinott G, Getahun M, Charlebois ED, Bond V.

AIDS. 2016 Mar 27;30(6):969-70. doi: 10.1097/QAD.0000000000001008. No abstract available.

7.

Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme.

Plazy M, Dabis F, Naidu K, Orne-Gliemann J, Barnighausen T, Dray-Spira R.

BMC Infect Dis. 2015 Oct 26;15:452. doi: 10.1186/s12879-015-1207-2.

8.

Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literature.

Plazy M, Orne-Gliemann J, Dabis F, Dray-Spira R.

BMJ Open. 2015 Jun 24;5(6):e006927. doi: 10.1136/bmjopen-2014-006927. Review.

9.

Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.

Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J; ANRS 12249 TasP Group.

BMC Public Health. 2015 Mar 1;15:209. doi: 10.1186/s12889-015-1344-y.

10.

Factors Associated with HIV Testing History among Pregnant Women and Their Partners in Georgia: The ANRS 12127 Prenahtest Trial.

Butsashvili M, Kajaia M, Kamkamidze G, Tchendjou P, Desgrees du Loû A, Dabis F, Orne-Gliemann J.

AIDS Res Treat. 2014;2014:356090. doi: 10.1155/2014/356090. Epub 2014 Sep 29.

11.

Defining and analyzing retention-in-care among pregnant and breastfeeding HIV-infected women: unpacking the data to interpret and improve PMTCT outcomes.

Rollins NC, Becquet R, Orne-Gliemann J, Phiri S, Hayashi C, Baller A, Shaffer N; INSPIRE Team.

J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S150-6. doi: 10.1097/QAI.0000000000000355.

PMID:
25310122
12.

Intimate partner sexual and physical violence among women in Togo, West Africa: prevalence, associated factors, and the specific role of HIV infection.

Burgos-Soto J, Orne-Gliemann J, Encrenaz G, Patassi A, Woronowski A, Kariyiare B, Lawson-Evi AK, Leroy V, Dabis F, Ekouevi DK, Becquet R.

Glob Health Action. 2014 May 26;7:23456. doi: 10.3402/gha.v7.23456. eCollection 2014.

13.

Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa.

Plazy M, Dray-Spira R, Orne-Gliemann J, Dabis F, Newell ML.

Trop Med Int Health. 2014 Jun;19(6):680-689. doi: 10.1111/tmi.12301. Epub 2014 Mar 21.

14.

HIV risk perception among pregnant women in western India: need for reducing vulnerabilities rather than improving knowledge!

Darak S, Gadgil M, Balestre E, Kulkarni M, Kulkarni V, Kulkarni S, Orne-Gliemann J; ANRS 12127 Prenahtest Study Group.

AIDS Care. 2014;26(6):709-15. doi: 10.1080/09540121.2013.855303. Epub 2013 Nov 11.

PMID:
24215183
15.

Willingness to use the Internet to seek information on HIV prevention and care among men who have sex with men in Ho Chi Minh City, Vietnam.

Justumus P, Colby D, Mai Doan Anh T, Balestre E, Becquet R, Orne-Gliemann J.

PLoS One. 2013 Aug 19;8(8):e71471. doi: 10.1371/journal.pone.0071471. eCollection 2013.

16.

Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.

Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, Imrie J, Bärnighausen T, Rekacewicz C, Bazin B, Newell ML, Dabis F; ANRS 12249 TasP Study Group.

Trials. 2013 Jul 23;14:230. doi: 10.1186/1745-6215-14-230.

17.

Increasing HIV testing among male partners.

Orne-Gliemann J, Balestre E, Tchendjou P, Miric M, Darak S, Butsashvili M, Perez-Then E, Eboko F, Plazy M, Kulkarni S, Desgrées du Loû A, Dabis F; Prenahtest ANRS 12127 Study Group.

AIDS. 2013 Apr 24;27(7):1167-77. doi: 10.1097/QAD.0b013e32835f1d8c.

PMID:
23343912
18.

A qualitative study on knowledge, perceptions, and attitudes of mothers and health care providers toward pneumococcal conjugate vaccine in Bandung, West Java, Indonesia.

Harjaningrum AT, Kartasasmita C, Orne-Gliemann J, Jutand MA, Goujon N, Koeck JL.

Vaccine. 2013 Mar 1;31(11):1516-22. doi: 10.1016/j.vaccine.2013.01.007. Epub 2013 Jan 11.

PMID:
23318150
19.

Factors associated with history of HIV testing among pregnant women and their partners in Cameroon: baseline data from a Behavioral Intervention Trial (ANRS 12127 Prenahtest).

Tchendjou PT, Koki PN, Eboko F, Malateste K, Essounga AN, Amassana D, Mossus T, Tejiokem M, Boisier P, Orne-Gliemann J.

J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S9-15. doi: 10.1097/QAI.0b013e31821ec6e2.

PMID:
21857289
20.

Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.

Tchendjou P, Same-Ekobo C, Nga A, Tejiokem M, Kfutwah A, Nlend AN, Tsague L, Bissek AC, Ekoa D, Orne-Gliemann J, Rousset D, Pouillot R, Dabis F.

PLoS One. 2010 Apr 29;5(4):e10411. doi: 10.1371/journal.pone.0010411.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk